Actinium Pharmaceuticals: A Small Cap Stock To Watch In The Biotech Space

actinium logoThe biotechnology sector has seen a multi-year rally that came to a halt only in mid-2015. However, the correction did not last long as the sector has seen a recovery in the last three months. The rebound highlights the fact that the sector remains robust.

Indeed, 2015 saw a record number of deals announced in the biotech sector. There were also a record number of FDA approvals in 2015.Read more